Bleeding and Contraception: Friends or Foes
Presented by Paula Castaño, MD MPH
Release Date: June 23, 2022
Expiration Date: June 23, 2023
Please complete the form at the bottom of this page in order to watch the archived webinar. You will be redirected to a new page to watch the webinar.
Physicians, CNMs, PAs, NPs and other healthcare professionals interested in OB/GYN and contraception.
Educational Needs Addressed
Abnormal uterine bleeding can often be managed by hormonal contraception. At the same time, bleeding changes are common side effects of most contraceptive methods. Learn about how to use contraception to manage abnormal uterine bleeding, and how to manage unfavorable bleeding for patients using combination oral contraceptive pills, progestin-only pills, medroxyprogesterone acetate injections, intrauterine devices, and subdermal levonorgestrel implants.
Participants at the conclusion of this webinar will be able to:
- Learn about the causes of abnormal uterine bleeding that are amenable to contraception management
- Describe recommendations for how to manage bleeding changes that occur with hormonal contraception
- Discuss best practices for conducting anticipatory counseling about abnormal bleeding and its management with patients
Katharine White, MD MPH
Vice-Chair of Academics, Department of OB/GYN, Boston Medical Center
Director of the Fellowship in Family Planning, Boston Medical Center
Associate Professor of Obstetrics and Gynecology, Boston University School of Medicine
Principal Investigator of Partners in Contraceptive Choice and Knowledge (PICCK)
Elisabeth Woodhams, MD MSc
Medical Director, BEACON Family Planning, Boston Medical Center
Associate Director of OB/GYN Residency Program, Boston Medical Center
Assistant Professor of Obstetrics and Gynecology, Boston University School of Medicine
Accreditor Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Paula Castaño, MD MPH
Faculty Presenter receives research support from Bayer Pharmaceuticals and is an instructor for Merck. She does plan on discussing unlabeled/investigational uses of a commercial product (medications not officially approved for bleeding management).
Katharine White, MD MPH receives research support from Boston Medical Center via Bayer Pharmaceuticals, Merck & Co., Inc., and Evofem Biosciences grants, and was previously a consultant for FitBit. Elisabeth Woodhams, MD MSc, Jenn Farraye, NP, Natasha Lerner, DrPH MPA, Kristina Tavilla, MPH, Elizabeth Raskin MPH(c) MSW(c), and Lily Acton, MPH of Boston Medical Center have no relevant financial relationships to disclose.
The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies:
Michael Burk, BS – Senior Program Manager
|Boston University School of Medicine
Barry M. Manuel Continuing Medical Education Office
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Partners in Contraceptive Choice and Knowledge. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Earn Credit
In order to successfully complete this activity, you are required to view the entire enduring webinar and complete a posttest and evaluation. The evaluation survey will appear at the end of this activity after the content presentation. In the last evaluation question select that you wish to receive CME credit.
How to Request a Certificate
By reviewing the course content and completing the posttest and evaluation, physicians are entitled to receive 1 AMA PRA Category 1 Credits™. To receive a certificate for your participation in this activity, you will need to complete the evaluation survey at the end of this activity and in the last question select that you wish to receive CME credit. PICCK will send your certificate directly to you via email. You can expect your certificate within two weeks of completing the evaluation survey.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
For questions about the program or technology, contact us.
For questions about accreditation, contact Boston University School of Medicine – CME Office at: (617) 358-5005 or firstname.lastname@example.org.